U.S. federal trademark · Serial No. 90295383 · Reg. No. 7565627
Pharmaceuticals for the treatment of agitation, namely, an orally-dissolving formulation used for the treatment of agitation associated with central nervous system disorders, namely, schizophrenia and bipolar disorder
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.